Biologics &
Injectables Index

Convert Unblinded
Payer Perceptions
into Insight

Track current and emerging trends about biologics and injectables with perspectives from payers, HCPs, office managers, representing 75% of Commercial and Medicare lives. Capture unblinded payer perceptions to drive insightful action.

Use the Biologics and Injectables Index to:

  • Examine payer reactions to relevant topics affecting healthcare each quarter
  • Assess high level payer management techniques, site of care dynamics, and administration burden via General Access Topics
  • Receive insight into the power dynamics between IDNs and payers

Learn More About MMIT’s Biologics and Injectables Index



Biologics & Injectables Index helps:

  • Understand which biologic and injectable agents are more commonly prescribed by HCPs and their familiarity with upcoming launches
  • View Practice Manager and HCP perception of administration burden for each brand
  • Uncover patient concerns that are most commonly discussed with their physician when looking for new starts on biologic and injectable therapies or when being forced to switch
biologics-and-injectables-product-image-in-laptop-thumbnails

Additional Resources

PULSE Checks

View an analysis of a single indication combining insights from Analytics, Message Monitor and Indices, with verbatims from payers and coverage data.

VIEW PULSE CHECKS

Related Solutions to Support Your Strategy

MMIT offers a variety of payer and IDN insights solutions.